A phase I study of binimetinib (MEK162) in Japanese patients with advanced solid tumors

Watanabe, K.; Otsu, S.; Hirashima, Y.; Morinaga, R.; Nishikawa, K.; Hisamatsu, Y.; Shimokata, T.; Inada-Inoue, M.; Shibata, T.; Takeuchi, H.; Watanabe, T.; Tokushige, K.; Maacke, H.; Shiaro, K.; Ando, Y.

期刊名称Cancer Chemotherapy and Pharmacology
作者Watanabe, K.; Otsu, S.; Hirashima, Y.; Morinaga, R.; Nishikawa, K.; Hisamatsu, Y.; Shimokata, T.; Inada-Inoue, M.; Shibata, T.; Takeuchi, H.; Watanabe, T.; Tokushige, K.; Maacke, H.; Shiaro, K.; Ando, Y.
卷第77卷
期第6期
印刷ISSN0344-5704
电子ISSN1432-0843
文件大小1610.89KB
发表时间2016-6-12
DOI10.1007/s00280-016-3019-5
页码1157-1164

发现好书期刊，享受阅读乐趣

A phase I study of binimetinib (MEK162) in Japanese patients with advanced solid tumors